BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37186582)

  • 1. Multi-omic modeling of antidepressant response implicates dynamic immune and inflammatory changes in individuals who respond to treatment.
    Fuh SC; Fiori LM; Turecki G; Nagy C; Li Y
    PLoS One; 2023; 18(5):e0285123. PubMed ID: 37186582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants.
    Ju C; Fiori LM; Belzeaux R; Theroux JF; Chen GG; Aouabed Z; Blier P; Farzan F; Frey BN; Giacobbe P; Lam RW; Leri F; MacQueen GM; Milev R; Müller DJ; Parikh SV; Rotzinger S; Soares CN; Uher R; Li Q; Foster JA; Kennedy SH; Turecki G
    Transl Psychiatry; 2019 Oct; 9(1):254. PubMed ID: 31594917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP.
    Powell TR; Smith RG; Hackinger S; Schalkwyk LC; Uher R; McGuffin P; Mill J; Tansey KE
    Transl Psychiatry; 2013 Sep; 3(9):e300. PubMed ID: 24002086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-project and Multi-profile joint Non-negative Matrix Factorization for cancer omic datasets.
    Salazar DA; Pržulj N; Valencia CF
    Bioinformatics; 2021 Dec; 37(24):4801-4809. PubMed ID: 34375392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response.
    Fiori LM; Orri M; Aouabed Z; Théroux JF; Lin R; Nagy C; Frey BN; Lam RW; MacQueen GM; Milev R; Müller DJ; Parikh SV; Rotzinger S; Uher R; Foster JA; Kennedy SH; Turecki G
    Transl Psychiatry; 2021 Aug; 11(1):439. PubMed ID: 34420030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder.
    Wang Y; Zhou J; Ye J; Sun Z; He Y; Zhao Y; Ren S; Zhang G; Liu M; Zheng P; Wang G; Yang J
    Microbiome; 2023 Aug; 11(1):195. PubMed ID: 37641148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early antidepressant treatment response prediction in major depression using clinical and TPH2 DNA methylation features based on machine learning approaches.
    Chen B; Jiao Z; Shen T; Fan R; Chen Y; Xu Z
    BMC Psychiatry; 2023 May; 23(1):299. PubMed ID: 37127594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1.
    Nunez JJ; Nguyen TT; Zhou Y; Cao B; Ng RT; Chen J; Frey BN; Milev R; Müller DJ; Rotzinger S; Soares CN; Uher R; Kennedy SH; Lam RW
    PLoS One; 2021; 16(6):e0253023. PubMed ID: 34181661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant.
    Hudgens S; Floden L; Blackowicz M; Jamieson C; Popova V; Fedgchin M; Drevets WC; Cooper K; Lane R; Singh J
    J Affect Disord; 2021 Feb; 281():767-775. PubMed ID: 33261932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers.
    Navinés R; Oriolo G; Horrillo I; Cavero M; Aouizerate B; Schaefer M; Capuron L; Meana JJ; Martin-Santos R
    Int J Neuropsychopharmacol; 2022 Jun; 25(6):468-478. PubMed ID: 35176771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment EEG signal variability is associated with treatment success in depression.
    Jaworska N; Wang H; Smith DM; Blier P; Knott V; Protzner AB
    Neuroimage Clin; 2018; 17():368-377. PubMed ID: 29159049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
    Hung YY; Lin CC; Kang HY; Huang TL
    Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
    Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
    J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylome-wide association study of antidepressant use in Generation Scotland and the Netherlands Twin Register implicates the innate immune system.
    Barbu MC; Huider F; Campbell A; Amador C; Adams MJ; Lynall ME; Howard DM; Walker RM; Morris SW; Van Dongen J; Porteous DJ; Evans KL; Bullmore E; Willemsen G; Boomsma DI; Whalley HC; McIntosh AM
    Mol Psychiatry; 2022 Mar; 27(3):1647-1657. PubMed ID: 34880450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTR1A/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients.
    Wang P; Lv Q; Mao Y; Zhang C; Bao C; Sun H; Chen H; Yi Z; Cai W; Fang Y
    J Affect Disord; 2018 Mar; 228():222-228. PubMed ID: 29275155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.
    Maneeton N; Maneeton B; Srisurapanont M; Martin SD
    BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder.
    Cussotto S; Delgado I; Oriolo G; Kemper J; Begarie D; Dexpert S; Sauvant J; Leboyer M; Aouizerate B; Martin-Santos R; Schaefer M; Capuron L
    Depress Anxiety; 2022 May; 39(5):407-418. PubMed ID: 35357051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review.
    Webb LM; Phillips KE; Ho MC; Veldic M; Blacker CJ
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine Learning Analysis of Blood microRNA Data in Major Depression: A Case-Control Study for Biomarker Discovery.
    Qi B; Fiori LM; Turecki G; Trakadis YJ
    Int J Neuropsychopharmacol; 2020 Nov; 23(8):505-510. PubMed ID: 32365192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.